PharmaDeals Corp-METRx

PharmaDeals Corp-METRx provides vital company metrics that enable comparison of the top 12 Pharmaceutical Companies deal strategies and activities.

Deal Performance Analytics and Index
Covering overall licensing and M&A activity (short and long term), therapeutic focus, plus deal activity relative to R&D spend, this is a key resource for all executives and analysts within biotechnology, pharmaceutical and the financial services sectors.
Key Learnings:
  • Which of the top 12 is the deal making leader for different therapeutic areas.
  • Who is striking the most deals in the short term.
  • How do they rank in terms of their long term deal strategies.
  • Who are the most acquisitive in the M&A sector
  • How are these companies balancing internal and external pipeline filling.
  • PharmaDeals Corp-METRx Latest Articles
  • AstraZeneca Ramps Up Deal-Making Activity Published: 30 Jan-2013
    By: Heather Cartwright
    Abstract Fulltext:
    Volume: 2013 Issue: 1
  • Sanofi Published: 30 Jan-2013
    By: Heather Cartwright; Taskin Ahmed
    Abstract Fulltext:
    Volume: 2013 Issue: 1
  • Roche Published: 30 Jan-2013
    By: Heather Cartwright; Taskin Ahmed
    Abstract Fulltext:
    Volume: 2013 Issue: 1
  • Pfizer Published: 30 Jan-2013
    By: Heather Cartwright; Taskin Ahmed
    Abstract Fulltext:
    Volume: 2013 Issue: 1
  • Novartis Published: 30 Jan-2013
    By: Heather Cartwright; Taskin Ahmed
    Abstract Fulltext:
    Volume: 2013 Issue: 1

Bookmarks

Bookmark PharmaDeals through one of these social networks.

Download FREE Pilot Edition
Complete the form, and we will email you a link to the November 2011 METRx Company Reports and the Review Article
First Name:
Last Name:
Company:
Email:
PharmaDeals Corp-METRx
ISSN 2047-7007

Published online
4 quarterly issues per year
Who should subscribe:
Analysts, M&A and corporate finance professionals in investment banks, hedge funds, large cap advisory and asset management firms.

Business development and competitive intelligence professionals, chief executives and other senior managers within pharmaceutical and biotechnology companies.

Published by
PharmaDeals Ltd, an IMS Health company

Pentonville Road
London
N1 9JY, UK


All enquires, including subscription information and permission requests:
Email: pdenquiries@@uk.imshealth.com
© IMS PharmaDeals Ltd 2013
All Rights Reserved. All users are expected to adhere to published Terms and Conditions for use. The contents of this publication is protected by international laws, and no part of this publication may be photocopied, transmitted or reproduced in any form.